|
Summary
September 2007, Vol. 4, No. 5, Pages 459-474
, DOI 10.1517/17425247.4.5.459
Needle-free vaccine deliveryGideon Kersten & Hoang Hirschberg1Head, Netherlands Vaccine Institute, Research and Development Department, PO Box 457, 3720 Al Bilthoven, The Netherlands +31 30 274 2925; gideon.kersten@nvi-vaccin.nl 2Scientist, Netherlands Vaccine Institute, Research and Development Department, PO Box 457, 3720 Al Bilthoven, The Netherlands The need for minimally invasive delivery methods is urgent. As the number of registered vaccines increases, so does the number of injections. The use of sharps can be unsafe and needle immunisation is less suitable for mass immunisations during emergencies such as pandemics or bioterrorist attacks. The approach of combining vaccines has limitations due to high development costs, risk of pharmaceutical or immunological interference and economic risks. Advancements in the development of alternatives to injection with syringes and needles are discussed in this paper, and include: mucosal vaccination, injection without needles and vaccine delivery via the skin. Forward Links to Citing ArticlesZhuo-Zhuang Lu, Xiao-Hui Zou, Liu-Xin Dong, Jian-Guo Qu, Jing-Dong Song, Min Wang, Li Guo, Tao Hung. (2009) Novel recombinant adenovirus type 41 vector and its biological properties. The Journal of Gene Medicine 11:2, 128-138 Online publication date: 1-Mar-2009. CrossRef Users who read this article also read:
|
|





&
TOC Alert